Amazon Ends Secret Fertility Tracker Project Amid Cost-Cutting Measures

CEO Andy Jassy's focus on efficiency leads to the termination of the ambitious 'Encore' initiative, part of Amazon's Grand Challenge division.

The project, codenamed 'Encore,' aimed to develop a saliva-based fertility tracking device and app, originating from Amazon's 2020 acquisition of bluDiagnostics.
Technical challenges and high costs delayed the product's launch, ultimately leading to its discontinuation along with other experimental projects.
Approximately 100 employees involved in the project will receive severance if they do not find new positions within Amazon by December 27.
Amazon's Grand Challenge division, known for bold projects, reflects former CEO Jeff Bezos's innovative approach, which contrasts with Jassy's cost-focused strategy.
Only one health tech project remains active within the Grand Challenge, as Amazon continues to streamline its operations.